Long COVID Trial, Recruiting (NCT06897553)

Long COVID Trial, Recruiting NCT06897553 Sponsor: Bielefeld University Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT06897553 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You score above a certain level on a questionnaire that measures depression, anxiety, and stress (called the DASS-21), meaning you are experiencing noticeable symptoms in at least one of these areas
You have enough thinking and language ability to take part, as judged by a clinician
You are motivated and willing to engage in therapy, as judged by a clinician

Who may not be able to join:

You have significant behavioral difficulties, such as high levels of irritability or very low motivation/engagement (apathy), as assessed by a clinician
You have another serious mental health condition, such as dementia, psychosis, a personality disorder, or an intellectual disability
You are currently receiving psychotherapy or neuropsychological therapy at the same time as this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katja Werheid, Prof, Bielefeld University

Phone: +49 (0) 521 106 67533

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06897553

Sponsor: Bielefeld University

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: +49 (0) 521 106 67533

More information: https://clinicaltrials.gov/study/NCT06897553

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You score above a certain level on a questionnaire that measures depression, anxiety, and stress (called the DASS-21), meaning you are experiencing noticeable symptoms in at least one of these areas
You have enough thinking and language ability to take part, as judged by a clinician
You are motivated and willing to engage in therapy, as judged by a clinician

Who may not be able to join:

You have significant behavioral difficulties, such as high levels of irritability or very low motivation/engagement (apathy), as assessed by a clinician
You have another serious mental health condition, such as dementia, psychosis, a personality disorder, or an intellectual disability
You are currently receiving psychotherapy or neuropsychological therapy at the same time as this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Bielefeld University

Registry

ClinicalTrials.gov

Start date

1 December 2024

Est. completion

31 August 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Depression and Anxiety Stress Scales-21 (Lovibond, 1995); Acceptance and Action Questionnaire-Acquired Brain Injury (Sylvester, 2011); Wechsler Adult Intelligence Scale - Fourth Edition (Similarities subtest; Wechsler, 2008)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov